Oncolytic Virotherapy - University of Florida
Download
Report
Transcript Oncolytic Virotherapy - University of Florida
Oncolytic Virotherapy
Reovirus: A Prototypical Wild-type Oncolytic Virus
By: Stephen Mayper
Cancer
Abnormal cell growth
Accumulated genetic &
epigenetic alterations
Healthy cells gone “haywire”
Numerous means of immune
response evasion
Conventional Treatments
Surgery
Tumor removal
Is ineffective against and
can induce metastasis
Inherent risk!
Conventional Treatments
Radiotherapy
Uses radiation to kill tumor
cells
Effective at reducing…
…Tumors!
…Aaaaand healthy cells
Can carry severe side
effects
(Creative representation if innocent
bystander cell death…)
Conventional Treatments
Chemotherapy
Use of pharmaceuticals to
kill tumor cells
It works!
…But it kills lots of other
cells indiscriminately
Emerging Treatment:
Virotherapy
Uses an oncolytic virus (OV)
to lyse cancer cells
Advantages:
High specificity means
fewer side effects
Self-regulating dosage
Lack of contraindications
Viruses currently being explored
Mumps virus
Pseudorabies virus
SV40 virus
Vaccinia virus
Coxsackie A virus
How does it work?
…Get it?
Virus can be…
Naturally occurring
Genetically engineered
Transcription targeting
Attenuation
Specificity generally
determined by antiviral
pathway deregulation
(It’s a virus in “nature!”)
Example: Adenovirus
Therapy Targeting Gliomas
Source: Maruniak, Jim. "Adenovirus." MCB 5505, Honors Virology. University of Florida, Gainesville, FL. 19 Feb. 2011. Lecture.
Another Mechanism of
Tumor Cell OV Susceptibility
Source: Chiocca EA. Oncolytic viruses. Nat Rev Cancer. 2002 Dec;2(12):938-50.
Reovirus
Reovirus Background
REOvirus = “Respiratory Enteric Orphan Virus”
Infect human respiratory & gastrointestinal tracts
“Orphaned” because originally not thought to
be associated with any disease
Several disease associations discovered since
Reoviruses are pervasive
Reovirus Taxonomy
Family: Reoviridae
Genera Infecting Vertebrates (6)
Orthoreovirus
Orbivirus
Coltivirus
Rotavirus
•African Horse Sickness
Mostly
•Colorado
Tick Fever
Asymptomatic
•Blue
Tongue Disease
Aquareovirus
Seadornavirus
(Percentage of gastroenteritis deaths)
Source: Cann, Alan. "Reoviruses." MicrobiologyBytes. 11 Sept. 2007. Web.
<http://www.microbiologybytes.com/virology/Reoviruses.html>.
Reovirus Structure
Spherical, 80 nm diameter
Non-enveloped
Isometric capsid
Concentric inner and
outer capsids
Sometimes middle capsid
(Inner capsid = “core”)
4 core proteins
λ-1, λ-3, μ-2, σ-2
Heat-stable
Stable @ pH= 3 – 9
Denatured by ethanol
Reovirus Genome
RNA
DoubleStranded
Linear
10-12 segments
(speciesdependent)
Reassortment
common in vitro
Encodes viral
replication
machinery
Source: http://education.expasy.org/images/Orthoreovirus_genome.jpg
Reovirus Reproduction
Replicates in the cytoplasm
Encodes its own replication machinery
Antiviral susceptibility
Does NOT fully uncoat
Core is resistant to protease digestion
No uncoating
No destruction by host cell
Genomic RNA stays in the core
Assembled virions form cytoplasmic inclusion bodies
Released via cell lysis
6 – 7 hour replication time
Reovirus Replication Illustrated
Questions?
Comments?
Sources
Cann, Alan. "Reoviruses." MicrobiologyBytes. 11 Sept. 2007. Web.
<http://www.microbiologybytes.com/virology/Reoviruses.html>.
Chiocca EA. Oncolytic viruses. Nat Rev Cancer. 2002 Dec;2(12):938-50.
Hammill AM, Conner J, Cripe TP. Oncolytic virotherapy reaches adolescence. Pediatr
Blood Cancer. 2010 Dec 15;55(7):1253-63. doi: 10.1002/pbc.22724. Epub 2010 Aug 23.
Maruniak, Jim. "Adenovirus." MCB 5505, Honors Virology. University of Florida,
Gainesville, FL. 19 Feb. 2011. Lecture.
Mertens P. The dsRNA viruses. Virus Res. 2004 Apr;101(1):3-13.
Nettelbeck DM. Cellular genetic tools to control oncolytic adenoviruses for
virotherapy of cancer. J Mol Med. 2008 Apr;86(4):363-77. Epub 2007 Dec 19.
Siegel, Robert. "Reoviruses." Stanford University. 1 Feb. 1999. Web. 20 Apr. 2011.
<http://www.stanford.edu/group/virus/1999/caryn/reovirus.html>.
Vähä-Koskela MJ, Heikkilä JE, Hinkkanen AE. Oncolytic viruses in cancer therapy.
Cancer Lett. 2007 Sep 8;254(2):178-216. Epub 2007 Mar 23.